Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"MP-III-024"”.

  1. SUBSTANCE USE DISORDERS AND THE BEHAVIORAL EFFECTS OF NOVEL AND EXISTING COMPOUNDS

    … aimed to study the effects of experimental compounds for use in treating and preventing substance use disorders, particularly opioid use disorder (OUD) and alcohol use disorder (AUD). Identifying and testing potential medications for these two diseases is critical since current FDA-approved …

    rowan Repository record for SUBSTANCE USE DISORDERS AND THE BEHAVIORAL EFFECTS OF NOVEL AND EXISTING COMPOUNDS (opens in a new tab)

  2. Behavioral Effects of Novel Treatments for Pain and Alcohol Use Disorder

    … co-administered with the novel imidazodiazepine, MP-III-024, synergistic effects in models of analgesia and antinociception are produced. Our research efforts were concerned with understanding if morphine in combination with MP-III-024 produced synergistic effects in measures of undesirable …

    rowan Repository record for Behavioral Effects of Novel Treatments for Pain and Alcohol Use Disorder (opens in a new tab)

  3. Behavioral Effects of Novel Treatments for Pain Management Using Combinatorial Methods

    … several different mechanisms within the body is important to discovering the optimal way to treat and manage a person’s pain. Modern medicine has seen numerous advancements in treating or managing acute and chronic pain, particularly with opioid drugs. However, these treatments come with potential …

    rowan Repository record for Behavioral Effects of Novel Treatments for Pain Management Using Combinatorial Methods (opens in a new tab)

  4. Searching for new analgesics without addiction risks

    … chronic pain. But opioid addiction to these compounds can cause social and life-threatening health problems, including the risk of overdose. In this thesis, I evaluated IBNtxA (3-iodobenzoyl naltrexamine), a novel mu opioid receptor (MOR) agonist structurally related to the classical MOR …

    rowan Repository record for Searching for new analgesics without addiction risks (opens in a new tab)

  5. Behavioral analysis of conditions and treatments affecting movement and nociception

    … delay the onset of the disease and prolong and improve the quality of life of young NPC patients. Finally, the last part of this thesis work includes studies on synergistic anithyperalgesic and antinociceptive effects of morphine and MP-III-024, a positive allosteric modulator at α2GABAA and …

    rowan Repository record for Behavioral analysis of conditions and treatments affecting movement and nociception (opens in a new tab)